Inhibrx: Prior to Closing of Merger, All Non-101 Assets & Liabilities Will Be Spun Out From Co Into a New Publicly Traded Company, Inhibrx Biosciences
Inhibrx:在合併結束之前,所有非101資產和負債將從公司分拆爲一家新的上市公司Inhibrx Biosciences
Inhibrx: Prior to Closing of Merger, All Non-101 Assets & Liabilities Will Be Spun Out From Co Into a New Publicly Traded Company, Inhibrx Biosciences
Inhibrx:在合併結束之前,所有非101資產和負債將從公司分拆爲一家新的上市公司Inhibrx Biosciences
譯文內容由第三人軟體翻譯。